跳至主要内容
临床试验/ITMCTR2000003688
ITMCTR2000003688尚未招募1 期

A randomized controlled trial for Wenyang Sanjie Decoction in the treatment of bone metastasis of lung cancer

onghua Hospital, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Patients with primary lung cancer confirmed by cytological or histopathological methods and confirmed by X-ray, CT, MRI, bone ECT, PET/CT and other imaging examinations;
  • (2) TCM syndrome differentiation is Yangxu Tanning;
  • (3) Patients with bone metastasis who could not receive chemoradiotherapy within 1 month, or over 1 month after the end of chemoradiotherapy;
  • (4) Aged > 18 years and <= 75 years;
  • (5) Karnofsky score >= 60, life expectancy >= 6 months;
  • (6) Allergic to traditional Chinese medicine, zoledronic acid and topical ointment;
  • (7) Understand and agree to receive the treatment, and sign the informed consent.

排除标准

  • (1) Pain accompanied by local redness, swelling and fever;
  • (2) Those who apply targeted drug therapy;
  • (3) Patients with severe heart, liver and kidney diseases or a history of mental illness;
  • (4) Poor compliance and incomplete data;
  • (5) Persons with a history of mental illness.

研究者

发起方
onghua Hospital, Shanghai University of Traditional Chinese Medicine

相似试验